drug

long-lasting injectable naltrexone

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by State University of New York - Upstate Medical University
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)
NCT00453609Phase 4Completed

KOLs & investigators

1
Steven L Batki, MDKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
State University of New York - Upstate Medical University
company
trial
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)
PHASE4
trial
indication
Schizophrenia
indication
Alcoholism
indication
Alcohol Dependence
indication
Bipolar Disorder
indication
KOL
Steven L Batki, MD
KOL score 5
person